Emmet Stephenson gives $150M to City of Hope for pancreatic cancer, creating million-dollar research prize

Lei Lei Wu

News Reporter

In honor of his wife who passed away from pancreatic cancer, tech entrepreneur Emmet Stephenson and his daughter Tessa Stephenson Brand are donating $150 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Emmet Stephenson gives $150M to City of Hope for pancreatic cancer, creating million-dollar research prize

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Stem cell startup spun out of George Church’s lab raises $75M

Here's what today's Fed rate cut means for biotech, pharma and venture capital

Edgewise’s stock surges as heart drug passes early safety test

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

Breaking down silos with a new quantitative approach to drug development

Em­met Stephen­son gives $150M to City of Hope for pan­cre­at­ic can­cer, cre­at­ing mil­lion-dol­lar re­search prize

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Stem cell start­up spun out of George Church’s lab rais­es $75M

Here's what to­day's Fed rate cut means for biotech, phar­ma and ven­ture cap­i­tal

Edge­wise’s stock surges as heart drug pass­es ear­ly safe­ty test

Ex­clu­sive: Flag­ship-backed Va­lo Health los­es in­ter­im CEO ahead of key Phase 2 read­out

FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

Emmet Stephenson gives $150M to City of Hope for pancreatic cancer, creating million-dollar research prize

Stem cell startup spun out of George Church’s lab raises $75M

Here's what today's Fed rate cut means for biotech, pharma and venture capital

Edgewise’s stock surges as heart drug passes early safety test

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

Breaking down silos with a new quantitative approach to drug development